Wellington Management

Asher Biotherapeutics, Inc. is a biotechnology company based in South San Francisco, California, founded in 2019. The company specializes in the development of immunotherapy drugs aimed at effectively treating cancer. Its innovative therapies are designed to enhance the immune system's ability to target and eliminate cancer cells while minimizing side effects. This focus allows healthcare providers to deliver effective treatments to patients in a shorter timeframe, aiming to improve overall outcomes in cancer care.

Quince, LLC is a retail company based in San Francisco, California, specializing in affordable luxury apparel, accessories, and home goods for both men and women. Founded in 2016, Quince offers a diverse range of products including jewelry, tops, sweaters, loungewear, leather goods, and various accessories for men, as well as bedding and bath items for the home. The company employs a manufacturer-to-consumer retail model, producing inventory on a near just-in-time basis, which allows for direct shipping to consumers. This approach not only reduces costs but also minimizes financial and environmental waste, enabling Quince to provide high-quality fashion and home products at competitive prices.

Quince, LLC is a retail company based in San Francisco, California, specializing in affordable luxury apparel, accessories, and home goods for both men and women. Founded in 2016, Quince offers a diverse range of products including jewelry, tops, sweaters, loungewear, leather goods, and various accessories for men, as well as bedding and bath items for the home. The company employs a manufacturer-to-consumer retail model, producing inventory on a near just-in-time basis, which allows for direct shipping to consumers. This approach not only reduces costs but also minimizes financial and environmental waste, enabling Quince to provide high-quality fashion and home products at competitive prices.

Faire is an online wholesale marketplace that connects retailers with unique merchandise from various brands and makers, facilitating a streamlined purchasing process. The platform provides retailers with tools and insights to manage inventory effectively, employing artificial intelligence and predictive analytics to forecast product demand. Faire's offerings include net 60 payment terms and free returns, which reduce the risks associated with wholesale purchasing, enabling local retailers and independent brands to compete with larger e-commerce entities. Headquartered in San Francisco and Kitchener, Faire aims to support the future of local retail by simplifying logistics and enhancing access to diverse products.

Asher Biotherapeutics, Inc. is a biotechnology company based in South San Francisco, California, founded in 2019. The company specializes in the development of immunotherapy drugs aimed at effectively treating cancer. Its innovative therapies are designed to enhance the immune system's ability to target and eliminate cancer cells while minimizing side effects. This focus allows healthcare providers to deliver effective treatments to patients in a shorter timeframe, aiming to improve overall outcomes in cancer care.

Faire is an online wholesale marketplace that connects retailers with unique merchandise from various brands and makers, facilitating a streamlined purchasing process. The platform provides retailers with tools and insights to manage inventory effectively, employing artificial intelligence and predictive analytics to forecast product demand. Faire's offerings include net 60 payment terms and free returns, which reduce the risks associated with wholesale purchasing, enabling local retailers and independent brands to compete with larger e-commerce entities. Headquartered in San Francisco and Kitchener, Faire aims to support the future of local retail by simplifying logistics and enhancing access to diverse products.

Patreon Inc. is a membership platform founded in 2013 and based in San Francisco, California, that enables artists and content creators to monetize their work through direct relationships with their fans. The platform allows patrons to support creators on a recurring basis in exchange for exclusive benefits and insights into the creative process. By facilitating connections between creators and their audiences, Patreon empowers a new generation of artists to earn a living from their passions. The platform hosts a wide variety of content, including videos, photographs, artwork, audio clips, and other creative materials, fostering a community where fans can actively participate in and support the work they admire.

Nuvation Bio Inc. is a biopharmaceutical company dedicated to developing innovative therapies for oncology, addressing unmet medical needs in the treatment of challenging cancers that have not responded to conventional therapies. Founded in 2018 and based in New York, with an additional office in San Francisco, the company has a portfolio of drug development candidates aimed at improving patient outcomes. One of its key clinical-stage candidates is NUV-868, an oral small molecule BET inhibitor that targets the BRD4 protein, which plays a crucial role in regulating tumor growth and differentiation. Additionally, Nuvation Bio is advancing its proprietary small molecule Drug-Drug Conjugate platform, further expanding its therapeutic arsenal in oncology.

Affirm is a financial technology company based in San Francisco, California, that specializes in providing installment loans to consumers at the point of sale. Founded in 2012, Affirm offers a platform that allows users to make purchases from online merchants and pay for them in fixed monthly installments. This service provides a transparent alternative to traditional credit cards, as it enables consumers to see upfront what they will pay each month, without hidden fees or unexpected costs. Affirm partners with over 2,000 merchants across various sectors, including retail, travel, and personal fitness, allowing shoppers to select Affirm as a payment option at checkout. The company aims to empower consumers with honest financial products and improve accessibility in the banking industry.

Patreon Inc. is a membership platform founded in 2013 and based in San Francisco, California, that enables artists and content creators to monetize their work through direct relationships with their fans. The platform allows patrons to support creators on a recurring basis in exchange for exclusive benefits and insights into the creative process. By facilitating connections between creators and their audiences, Patreon empowers a new generation of artists to earn a living from their passions. The platform hosts a wide variety of content, including videos, photographs, artwork, audio clips, and other creative materials, fostering a community where fans can actively participate in and support the work they admire.

Satsuma Pharmaceuticals is a clinical-stage biopharmaceutical company focused on developing innovative treatments for migraine. The company's lead product candidate, STS101, is a drug-device combination that features a proprietary dry-powder formulation of dihydroergotamine mesylate. This product is designed for self-administration through a pre-filled, single-use nasal delivery device and is currently undergoing Phase III clinical trials. Founded in 2016 and based in South San Francisco, California, Satsuma aims to provide an effective therapeutic option for individuals suffering from acute migraine episodes.

Affirm is a financial technology company based in San Francisco, California, that specializes in providing installment loans to consumers at the point of sale. Founded in 2012, Affirm offers a platform that allows users to make purchases from online merchants and pay for them in fixed monthly installments. This service provides a transparent alternative to traditional credit cards, as it enables consumers to see upfront what they will pay each month, without hidden fees or unexpected costs. Affirm partners with over 2,000 merchants across various sectors, including retail, travel, and personal fitness, allowing shoppers to select Affirm as a payment option at checkout. The company aims to empower consumers with honest financial products and improve accessibility in the banking industry.

Atreca, Inc. is a biopharmaceutical company based in South San Francisco, California, focused on discovering and developing antibody-based immunotherapeutics for various solid tumor types. Its lead product candidate, ATRC-101, is a monoclonal antibody currently in clinical development, characterized by a novel mechanism of action. ATRC-101 has demonstrated reactivity in vitro with a significant majority of human cancer samples, including ovarian, non-small cell lung, colorectal, and breast cancers. Atreca employs a unique technology to identify antibodies produced during immune responses without prior knowledge of antigens. The company collaborates strategically with Merck Sharp & Dohme Corp. to pinpoint antigenic targets of selected antibodies that may have applications in oncology. Founded in 2010, Atreca is dedicated to advancing innovative treatments for cancer.

Tricida, Inc. is a late-stage pharmaceutical company based in South San Francisco, California, dedicated to the development and commercialization of its lead drug candidate, TRC101. This non-absorbed, orally-administered polymer is designed to treat metabolic acidosis, a condition often associated with chronic kidney disease (CKD). Metabolic acidosis can contribute to the progression of CKD and is linked to various health issues such as muscle wasting, loss of bone density, and increased mortality risk. Tricida has successfully completed a Phase 3, double-blind, placebo-controlled trial of TRC101, aiming to provide an effective treatment option for patients suffering from this condition. The company was founded in 2013 and is focused on addressing the unmet medical needs of individuals with CKD.

Compass is a real estate technology company that offers an integrated online platform designed for buying, renting, and selling real estate assets. Founded in 2012 by Ugo Di Girolamo, Ori Allon, and Robert Reffkin in New York, Compass aims to enhance the real estate transaction process by combining top industry talent with advanced technology. Its platform provides an array of cloud-based software tools tailored for real estate agents, facilitating customer relationship management, marketing, and client service. Operating in over 22 regions across the United States, including major markets like New York, Los Angeles, Chicago, and San Francisco, Compass supports agents in delivering exceptional service to their clients, thereby streamlining the entire buying and selling workflow.

Atreca, Inc. is a biopharmaceutical company based in South San Francisco, California, focused on discovering and developing antibody-based immunotherapeutics for various solid tumor types. Its lead product candidate, ATRC-101, is a monoclonal antibody currently in clinical development, characterized by a novel mechanism of action. ATRC-101 has demonstrated reactivity in vitro with a significant majority of human cancer samples, including ovarian, non-small cell lung, colorectal, and breast cancers. Atreca employs a unique technology to identify antibodies produced during immune responses without prior knowledge of antigens. The company collaborates strategically with Merck Sharp & Dohme Corp. to pinpoint antigenic targets of selected antibodies that may have applications in oncology. Founded in 2010, Atreca is dedicated to advancing innovative treatments for cancer.

Compass is a real estate technology company that offers an integrated online platform designed for buying, renting, and selling real estate assets. Founded in 2012 by Ugo Di Girolamo, Ori Allon, and Robert Reffkin in New York, Compass aims to enhance the real estate transaction process by combining top industry talent with advanced technology. Its platform provides an array of cloud-based software tools tailored for real estate agents, facilitating customer relationship management, marketing, and client service. Operating in over 22 regions across the United States, including major markets like New York, Los Angeles, Chicago, and San Francisco, Compass supports agents in delivering exceptional service to their clients, thereby streamlining the entire buying and selling workflow.

Airbnb, Inc. operates a global online platform that connects hosts with guests seeking short-term accommodations and unique experiences. Founded in 2007 and headquartered in San Francisco, the company facilitates bookings for a diverse range of lodging options, including private rooms, luxury villas, and boutique hotels. As one of the largest alternative accommodation travel agencies in the world, Airbnb's marketplace model allows over 5 million hosts to list their properties, resulting in more than 8 million active accommodation listings across nearly every country. The company generates revenue primarily through transaction fees on online bookings, with a significant portion of its earnings coming from the North American region.

CytomX Therapeutics is an oncology-focused biopharmaceutical company based in South San Francisco, California. The company specializes in developing proteolytically-activated antibody therapeutics using its proprietary Probody technology platform. This innovative approach aims to create cancer immunotherapies that enhance targeting of tumor cells while minimizing effects on healthy tissues. CytomX's clinical-stage product candidates include CX-072, which targets programmed cell death ligand 1; CX-2009, a drug conjugate against CD166; and BMS-986249, a CTLA-4 Probody therapeutic for metastatic melanoma, among others. The company has established strategic collaborations with several major pharmaceutical companies, including AbbVie, Amgen, and Bristol-Myers Squibb, to further the development of its Probody therapeutics. Founded in 2008, CytomX is dedicated to providing patients with more effective and less toxic treatment options for cancer and inflammatory diseases.

DocuSign, Inc. is a leading provider of cloud-based software that facilitates electronic signatures and automates agreement workflows for businesses and individuals. Founded in 2003 and headquartered in San Francisco, the company offers a comprehensive platform known as Agreement Cloud, which streamlines various aspects of documented transactions, including identity management, authentication, and data collection. DocuSign's solutions cater to a diverse range of sectors, including finance, healthcare, technology, and real estate, and serve small to large enterprises. Key offerings include DocuSign CLM for automating agreement processes, Intelligent Insights leveraging artificial intelligence for agreement analysis, and integrations with platforms like Salesforce. Additionally, the company provides tools for complex forms, digital payments, and electronic notarization. DocuSign operates globally, with offices in major cities such as London, Sydney, São Paulo, and Dublin, and offers training and support services to enhance user experience.